(Total Views: 572)
Posted On: 05/17/2021 3:46:11 PM
Post# of 145248
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: craigakess #90451
The FDA is correct in that the endpoints failed. Of course no explanation by the FDA of why the endpoints failed including the FDA not allowing us 4 doses in the severe/critical trial. We know leronlimab is showing clinical benefit and the FDA will be backpedaling after the Brazil trials.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)